’Clinical trial funding insurance is a revolutionary new insurance product that has huge unmet demand,’ says chief executive officer
Asta has been granted in principle approval from Lloyd’s of London to establish a syndicate to deliver a product that will aid the development of new therapeutic drugs.
Read more…
Explore more London market content here or discover other news stories here
We’re glad you’ve chosen Insurance Times as your source for industry news and hope you’ve been enjoying reading articles from our award-winning team of journalists.
Gain access to more of our exclusive, breaking stories, interviews and news analysis as it happens. Registering is quick, easy, free, and will also have the additional benefits:
Stay on top of the insurance game with our subscription! Get unlimited access to over 80,000 articles, in-depth analysis, exclusive reports by industry experts, and our Five-Star rating system to compare companies and find the best fit for your business needs - view subscription options.